Isoxepac-d6
Isoxepac-d6 (HP 549-d6) is the deuterium labeled Isoxepac (HY-W050088) . Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases[1].
Product Specifications
CAS Number
[2012598-71-7]
Product Name Alternative
HP 549-d6
UNSPSC
12352005
Target
Drug Derivative; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Inflammation/Immunology; Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CC(O)=O)=CC=C2OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C31
Molecular Formula
C16H6D6O4
Molecular Weight
274.30
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Caenorhabditis elegans LIM and SH3 domain protein F42H10.3 (F42H10.3)
Recombinant Caenorhabditis elegans LIM and SH3 domain protein F42H10.3 (F42H10.3)
Recombinant Caenorhabditis elegans LIM and SH3 domain protein F42H10.3 (F42H10.3)
Recombinant Caenorhabditis elegans LIM and SH3 domain protein F42H10.3 (F42H10.3)
Recombinant Caenorhabditis elegans LIM and SH3 domain protein F42H10.3 (F42H10.3)